QIAGEN Bioinformatics and NGS Solutions Enable Genomic Breakthroughs
October 12 2017 - 4:05PM
PR Newswire (US)
HILDEN, Germany and GERMANTOWN, Maryland, October 12, 2017 /PRNewswire/ --
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today
announced that its Sample to Insight solutions, from
next-generation sequencing (NGS) technologies to bioinformatics
solutions for research and clinical testing, figure prominently in
independent studies presented this week at the American Society of
Human Genetics (ASHG) annual meeting in Orlando, Florida. The ASHG 2017 conference,
from October 17-21, attracts leaders
in research and clinical applications from around the world,
offering scientific sessions on new technologies in molecular
biology and discoveries regarding genomic influences on
disease.
Click here for the full press release
https://corporate.qiagen.com/newsroom/press-releases/2017/2017-10-12-ASHG-Abstracts?sc_lang=en
Contacts:
QIAGEN
Investor Relations
John Gilardi
e-mail: ir@QIAGEN.com
+49-2103-29-11711
Public Relations
Dr. Thomas Theuringer
e-mail: pr@QIAGEN.com
+49-2103-29-11826
SOURCE Qiagen N.V.
Copyright 2017 PR Newswire
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Sep 2023 to Sep 2024